User profiles for E. N. Jonsson
Niclas JonssonPharmetheus AB Verified email at pharmetheus.com Cited by 7339 |
Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
EN Jonsson, MO Karlsson - Computer methods and programs in …, 1998 - Elsevier
The building of population pharmacokinetic/pharmacodynamic (PK/PD) models is a time
consuming and complicated task. This is partly due the lack of specialized tools for the …
consuming and complicated task. This is partly due the lack of specialized tools for the …
Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming
L Lindbom, J Ribbing, EN Jonsson - Computer methods and programs in …, 2004 - Elsevier
The NONMEM program is the most widely used nonlinear regression software in population
pharmacokinetic/pharmacodynamic (PK/PD) analyses. In this article we describe a …
pharmacokinetic/pharmacodynamic (PK/PD) analyses. In this article we describe a …
Automated covariate model building within NONMEM
EN Jonsson, MO Karlsson - Pharmaceutical research, 1998 - Springer
Purpose. One important task in population pharmacokinetic/pharmacodynamic model
building is to identify the relationships between the parameters and demographic factors (…
building is to identify the relationships between the parameters and demographic factors (…
Assessment of actual significance levels for covariate effects in NONMEM
U Wählby, EN Jonsson, MO Karlsson - Journal of pharmacokinetics and …, 2001 - Springer
The objectives of this study were to assess the difference between actual and nominal
significance levels, as judged by the likelihood ratio test, for hypothesis tests regarding covariate …
significance levels, as judged by the likelihood ratio test, for hypothesis tests regarding covariate …
Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis
U Wählby, EN Jonsson, MO Karlsson - Aaps Pharmsci, 2002 - Springer
The aim of this study was to compare 2 stepwise covariate model-building strategies,
frequently used in the analysis of pharmacokinetic-pharmacodynamic (PK-PD) data using …
frequently used in the analysis of pharmacokinetic-pharmacodynamic (PK-PD) data using …
A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy
The aim of this study was to characterize the relationship between warfarin concentrations
and international normalized ratio (INR) response and to identify predictors important for dose …
and international normalized ratio (INR) response and to identify predictors important for dose …
Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients
MO Karlsson, EN Jonsson, CG Wiltse… - … of pharmacokinetics and …, 1998 - Springer
Deriving a population pharmacokinetic model from real data is always associated with
numerous assumptions. Violations of these assumptions, especially if undetected, may lead to …
numerous assumptions. Violations of these assumptions, especially if undetected, may lead to …
Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: Kp, Kp, u, and Kp, uu
…, P Chatelain, R Massingham, EN Jonsson… - Drug metabolism and …, 2006 - ASPET
The objective of this study was to compare the blood-brain barrier (BBB) transport and brain
distribution of levo- (R-CZE) and dextrocetirizine (S-CZE). Microdialysis probes, calibrated …
distribution of levo- (R-CZE) and dextrocetirizine (S-CZE). Microdialysis probes, calibrated …
A comprehensive hepatitis C viral kinetic model explaining cure
…, M Lavielle, P Jacqmin, EN Jonsson… - Clinical …, 2010 - Wiley Online Library
We propose a model that characterizes and links the complexity and diversity of clinically
observed hepatitis C viral kinetics to sustained virologic response (SVR)—the primary clinical …
observed hepatitis C viral kinetics to sustained virologic response (SVR)—the primary clinical …
A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age
The objective of the study was to update a previous NONMEM model to describe the relationship
between warfarin dose and international normalized ratio (INR) response, to decrease …
between warfarin dose and international normalized ratio (INR) response, to decrease …